Javascript must be enabled to continue!
Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
View through CrossRef
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs). PGCCs have the properties of cancer stem cell. In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo. In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines. Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry. The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation. Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium. Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes. Activation of PPARγ is a critical step in the process of adipogenic differentiation. The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231. P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium. The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Springer Science and Business Media LLC
Title: Different p53 Genotypes Regulate PPARγ Post-Translational Modification in The Adipogenic Differentiation of Cancer Cells
Description:
Abstract
Background: Our previous studies confirmed that high concentrations of cobalt chloride (CoCl2) can induce the formation of polyploid giant cancer cells (PGCCs).
PGCCs have the properties of cancer stem cell.
In this study, we demonstrate that PGCCs can be induced to differentiate into adipose in vitro and in vivo.
In addition, the molecular mechanism of adipogenic differentiation of PGCCs with daughter cells was investigated by detecting the expression of adipocyte differentiation related proteins in mutant and wild-type p53 cancer cell lines.
Methods: HEY and MDA-MB-231 control cells and PGCCs with daughter cells were cultured with adipogenic differentiation medium and the cell cycle was detected by flow cytometry.
The expression of adipocyte differentiation related proteins, and P300 histone acetyltransferase activity were compared before and after adipogenic differentiation.
Immunoprecipitation was used to analyze the post-translational modification of peroxisome proliferator-activator receptor-γ (PPARγ) and P53 in HEY and MDA-MB-231 control cells and PGCCs with daughter cells cultured with adipogenic differentiation medium.
Animal xenograft models were used to study the adipogenic differentiation of PGCCs with daughter cells.
Results: Dexamethasone, rosiglitazone, insulin, and 3-isobutyl-1-methylxanthine (IBMX) can force the trans-differentiation of PGCCs into post-mitotic and functional adipocytes.
Activation of PPARγ is a critical step in the process of adipogenic differentiation.
The expression levels of p-CREBser133, PPARγ, C/EBPα, C/EBPβ were higher in PGCCs with daughter cells after adipogenic differentiation compared with those without adipogenic differentiation in HEY and MDA-MB-231.
P53 regulates the acetylation and phosphorylation of PPARγ and the expression of P300- Acetyl-PPARγ(Lys)- FABP4 and ERK- Phospho-PPARγ (Ser112)-FABP4 depended upon the genotype of p53 in HEY and MDA-MB-231 cells after cultured with adipogenic differentiation medium.
The invasion and migration abilities of PGCCs with their daughter cells after adipogenic differentiation decreased compared with those cells without adipogenic differentiation.
Conclusion: P300-P53-ERK-CREB-PPARγ-CEBPα/β-FABP4 pathway may participate in the adipogenic differentiation of HEY, MDA-MB-231 PGCCs with daughter cells, which associated with genotype of p53.
Related Results
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract 3500: Mitochondrially targeted p53 domains as a stand alone or adjunct to paclitaxel for the treatment of ovarian cancer
Abstract
Although the main function of p53 is a nuclear transcription factor that has important roles in cell cycle arrest, DNA repair, and apoptosis, p53 can direct...
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
High P53 Protein Expression Level Independent of Mutational Status Is An Adverse Prognostic Factor for Survival in Acute Myeloid Leukemia
Abstract
Abstract 1490
Background:
The tumor suppressor p53 is frequently mutated in human cancer, including acut...
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has ...
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Id4 dependent acetylation restores mutant-p53 transcriptional activity
Abstract
Background
The mechanisms that can restore biological activity of mutant p53 are an area of high interest given that mutant p53 expressi...
Abstract 1716: A small molecule corrector for p53 mutants found in cancer
Abstract 1716: A small molecule corrector for p53 mutants found in cancer
Abstract
p53 is the main tumor suppressor protein in vertebrates and the most frequently mutated gene in human cancers. The majority of p53 mutations are missense mu...
Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53
Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53
The E1 region of adenovirus (Ad) type 5 is capable of transforming cells. According to current concepts, the Ad E1B 55 kDa (E1B 55K) protein enables transformed cells to grow by co...
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract 1728: Overactivation of tumor suppressor P53 in hepatocytes promotes hepatocarcinogenesis
Abstract
Aim: p53 is a tumor suppressor and its dysfunction promotes carcinogenesis of several organs including the liver. Meanwhile, p53 is reported to be overactiv...
Abstract 1627: Chloroquine-induced inhibition of Arginase-1 promotes the nuclear localization of p53 in colon cancer cell lines
Abstract 1627: Chloroquine-induced inhibition of Arginase-1 promotes the nuclear localization of p53 in colon cancer cell lines
Abstract
Emerging studies have identified the overexpression of Arginase-1 (ARG-1) in a variety of human malignancies, including cancer of the colon, leading to the ...


